Assignee profile:

ACCERA, INC.

City:

Broomfield, Colorado

Country:

United States

Published Applications:

15

Last publication date:

2014-09-11

Patent Grants:

8

Last grant date:

2017-03-28

Top Inventors for applications by ACCERA, INC.

These are the the leading inventors for applications assigned to ACCERA, INC.:

Recent patent applications by ACCERA, INC.

ACCERA, INC. based in Broomfield, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-09-11
US20140256808A1
Human necessities

Use of Ketogenic Compounds for Treatment of Age-Associated Memory Impairment

#2 | 2013-08-29 ✅ Patent 9,603,823 granted on 2017-03-28
US20130225682A1
Human necessities

Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II

#3 | 2013-05-21 ✅ Patent 8,445,535 granted on 2013-05-21
US11021920
-

Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II

#4 | 2013-01-03
US20130005693A1
Human necessities

Method for Reducing Levels of Disease Associated Proteins

#5 | 2012-08-02 ✅ Patent 8,426,468 granted on 2013-04-23
US20120196932A1
Human necessities

Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism

#6 | 2012-05-17 ✅ Patent 8,748,400 granted on 2014-06-10
US20120122978A1
Human necessities

Use of ketogenic compounds for treatment of age-associated memory impairment

#7 | 2011-10-06 ✅ Patent 9,175,345 granted on 2015-11-03
US20110243885A1
Human necessities

Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function

#8 | 2011-07-21 ✅ Patent 9,125,881 granted on 2015-09-08
US20110178032A1
Human necessities

Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders

#9 | 2010-10-14
US20100261791A1
Human necessities

Compositions and Methods for Improving or Preserving Brain Function

#10 | 2010-02-18
US20100041751A1
Human necessities

Method to Reduce Oxidative Damage and Improve Mitochondrial Efficiency

#11 | 2010-01-07 ✅ Patent 8,105,809 granted on 2012-01-31
US20100003730A1
Chemistry; metallurgy

Enzymatic synthesis of acetoacetate esters and derivatives

#12 | 2008-11-20 ✅ Patent 8,124,589 granted on 2012-02-28
US20080287372A1
Human necessities

Use of ketogenic compounds for treatment of age-associated memory impairment

#13 | 2008-01-10
US20080009467A1
Human necessities

COMBINATIONS OF MEDIUM CHAIN TRIGLYCERIDES AND THERAPEUTIC AGENTS FOR THE TREATMENT AND PREVENTION OF ALZHEIMERS DISEASE AND OTHER DISEASES RESULTING FROM REDUCED NEURONAL METABOLISM

#14 | 2007-08-02
US20070179197A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING OR PRESERVING BRAIN FUNCTION

#15 | 2007-06-14
US20070135376A1
Human necessities

METHOD TO REDUCE OXIDATIVE DAMAGE AND IMPROVE MITOCHONDRIAL EFFICIENCY

Also check out Accera, Inc.'s (Broomfield, United States) applicant profile with 2 patent applications submitted.

AssigneeID:

1913 ⎘